Study: What is the Role of Fibrocytes and Endothelial Progenitor Cells in Lung Sarcoidosis?
source: pixabay.com

Study: What is the Role of Fibrocytes and Endothelial Progenitor Cells in Lung Sarcoidosis?

A study published in BMC Pulmonary Medicine focuses on the role of endothelial progenitor cells and fibrocytes in lung sarcoidosis. They specifically investigated how these cells, along with CD34 + cells, spurred…

Continue Reading Study: What is the Role of Fibrocytes and Endothelial Progenitor Cells in Lung Sarcoidosis?
GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers
Source: Pixabay.com

GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers

According to OncLive, Oncolytics Biotech and Roche are pairing up to run a new German Phase ½ clinical trial. The GOBLET trial will evaluate pelareorep in conjunction with atezolizumab (Tecentriq)…

Continue Reading GOBLET Clinical Trial to Evaluate Pelareorep & Atezolizumab for Pancreatic, Anal Cancers
Setmelanotide Shows Positive Results in BBS and Alstrom Syndrome
source: pixabay.com

Setmelanotide Shows Positive Results in BBS and Alstrom Syndrome

In a recent press release, biopharmaceutical company Rhythm Pharmaceuticals (“Rhythm”) announced positive data from a Phase 3 clinical trial. During the trial, Rhythm evaluated setmelanotide for patients with Bardet-Biedl syndrome…

Continue Reading Setmelanotide Shows Positive Results in BBS and Alstrom Syndrome
Rare Classroom: Sarcoidosis
source: shutterstock

Rare Classroom: Sarcoidosis

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Sarcoidosis
Health Canada Approves Hyrimoz for Ankylosing Spondylitis
stevepb / Pixabay

Health Canada Approves Hyrimoz for Ankylosing Spondylitis

According to GlobeNewswire, Health Canada has approved of a biosimilar, Hyrimoz, to treat ankylosing spondylitis and eight other rare conditions. Sandoz Canada is excited about this approval, as it expands…

Continue Reading Health Canada Approves Hyrimoz for Ankylosing Spondylitis
Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment
source: pixabay.com

Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment

Albireo has recently initiated their Phase 3 ASSERT trial, according to GlobeNewswire. This study will evaluate odevixibat as a treatment for Alagille syndrome. This therapy fits well with Albireo's mission,…

Continue Reading Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment
Study Shows Glaucoma and Other Eye Conditions May be Linked to Alzheimer’s Disease
source: pixabay.com

Study Shows Glaucoma and Other Eye Conditions May be Linked to Alzheimer’s Disease

Researchers have uncovered that there is a link between Alzheimer's disease and three eye conditions- glaucoma, diabetic retinopathy, and macular degeneration (age-related). This could mean that there may be another…

Continue Reading Study Shows Glaucoma and Other Eye Conditions May be Linked to Alzheimer’s Disease